It is started at a lower dose and then gradually increased over the weeks
Risks of Off-Label Use and Compounded GLP-1 Drugs Off-label use, using a drug to treat a condition its not approved for, can result in adverse reactions
Common side effects of semaglutide and tirzepatide include nausea, vomiting, diarrhea, constipation and decreased appetite
Indirect effects An indirect pathway for GLP-1RAs to mediate risk for PDAC is via acute or chronic pancreatitis, which are risk factors for PDAC 24,25
Also, the effects of detox water on the skin can vary with skin type
Analysts note that Orforgliprons success may not only capture market share from injectables but also expand access to GLP-1 therapies for broader populations